Clinical features of immune checkpoint inhibitor-induced inflammatory arthritis differ in those treated with combination versus single agent therapy

被引：0
|
作者：
Cappelli, Laura
Bingham, Clifton
Brahmer, Julie
Forde, Patrick
Le, Dung
Lipson, Evan
Naidoo, Jarushka
Zhang, Lei
Shah, Ami
机构：
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2017年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P445
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Baseline Clinical Features, but Not Shared Epitope or HLA B27, Predict Severe Outcomes for Immune Checkpoint Inhibitor-induced Inflammatory Arthritis
    Cappelli, Laura
    Kamal, Omer
    Jones, Michelle
    Bingham, Clifton
    Shah, Ami
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2115 - 2117
  • [32] Effectiveness of anti-inflammatory therapy in immune checkpoint inhibitor-induced diarrhoea/colitis
    Ibraheim, H.
    Samaan, M.
    Powell, N.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S347 - S347
  • [33] EFFECTIVENESS OF ANTI-INFLAMMATORY THERAPY IN IMMUNE CHECKPOINT INHIBITOR-INDUCED DIARRHOEA/COLITIS
    Ibraheim, Hajir
    Samaan, Mark A.
    Powell, Nick
    GASTROENTEROLOGY, 2018, 154 (06) : S913 - S913
  • [34] EFFECTIVENESS OF ANTI-INFLAMMATORY THERAPY IN IMMUNE CHECKPOINT INHIBITOR-INDUCED DIARRHOEA/COLITIS
    Ibraheim, Hajir
    Samaan, Mark
    Powell, Nick
    GUT, 2018, 67 : A79 - A79
  • [35] Higher levels of VEGF-A and TNFα in patients with immune checkpoint inhibitor-induced inflammatory arthritis
    Elise F. Gray-Gaillard
    Ami A. Shah
    Clifton O. Bingham III
    Jennifer H. Elisseeff
    Joseph Murray
    Julie Brahmer
    Patrick Forde
    Valsamo Anagnostou
    Jennifer Mammen
    Laura C. Cappelli
    Arthritis Research & Therapy, 27 (1)
  • [36] First use of tofacitinib to treat an immune checkpoint inhibitor-induced arthritis
    Murray, Kieran
    Floudas, Achilleas
    Murray, Ciara
    Fabre, Aurelie
    Crown, John
    Fearon, Ursula
    Veale, Douglas
    BMJ CASE REPORTS, 2021, 14 (02)
  • [37] Clinical feature of immune checkpoint inhibitor-induced pancreatic injury
    Itani, Junichiro
    Ishikawa, Takeshi
    Doi, Toshifumi
    Sone, Daiki
    Morita, Ryuichi
    Iwai, Naoto
    Hirose, Ryohei
    Inoue, Ken
    Dohi, Osamu
    Yoshida, Naohisa
    Uchiyama, Kazuhiko
    Takagi, Tomohisa
    Konishi, Hideyuki
    Itoh, Yoshito
    CANCER RESEARCH, 2024, 84 (06)
  • [38] TWO DISTINCT SUBSETS OF IMMUNE CHECKPOINT INHIBITOR-INDUCED INFLAMMATORY ARTHRITIS DEFINED BY LATENT CLASS ANALYSIS
    Cappelli, L.
    Perin, J.
    Bingham, C.
    Shah, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1979 - 1980
  • [39] Identification of Elevated Soluble Factors in Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis and Their Association with Severity and Persistence
    Gray-Gaillard, Elise
    Bingham, Clifton
    Shah, Ami
    Cappelli, Laura
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4051 - 4053
  • [40] Pain and Physical Function, but Not Fatigue, Track with Disease Activity in Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis
    Cappelli, Laura
    Eaton, Cyd
    Wang, Yunzhi
    Jones, Michelle
    Bingham, Clifton
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4071 - 4073
12345